The regulator joins the EU regulator in refusing to register Leqembi, which gave similar reasons for its position on the drug ...

My loving mom was not herself that day in 2016. She needed to process her diagnosis, which is perhaps why she lashed out.

Alzheimer’s disease is a progressive condition affecting memory and cognitive function. While no cure exists, adopting ...

A NEW laser test could be rolled out in GP surgeries to detect dementia in just seconds, scientists have said. The groundbreaking project has been a collaboration between experts at University ...

Data from a new study suggests that in the early phase the damage to the brain starts slowly, before speeding up in the ...

More than 850,000 people are living with dementia in the UK, with numbers expected to rise to 1.4 million by 2040 ...

Alzheimer’s disease may damage the brain in two phases, according to new research published in Nature Neuroscience on Monday.

Finding indicators of a predisposition to Alzheimer's disease. Identifying cardiovascular and diabetic risk factors. These could be possible through the ...

Discover key findings on the link between traumatic brain injury and Alzheimer’s disease, emphasizing BAG3's potential in ...

Australia's medicines watchdog has refused to register Lecanemab in Australia. The drug's sponsor company says it plans to ...

Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis. Targeting neuroinflammation with small molecules is promising, but ...